Lima VD - Search Results

1

Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada.

Nosyk B, Colley G, Yip B, Chan K, Heath K, Lima VD, Gilbert M, Hogg RS, Harrigan PR, Montaner JS; STOP HIV/AIDS Study Group. Nosyk B, et al. Among authors: lima vd. PLoS One. 2013;8(1):e54416. doi: 10.1371/journal.pone.0054416. Epub 2013 Jan 28. PLoS One. 2013. PMID: 23382898 Free PMC article.

2

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART.

Lima VD, Kretz P, Palepu A, Bonner S, Kerr T, Moore D, Daniel M, Montaner JS, Hogg RS. Lima VD, et al. AIDS Res Ther. 2006 May 24;3:14. doi: 10.1186/1742-6405-3-14. AIDS Res Ther. 2006. PMID: 16723028 Free PMC article.

3

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.

Hogg RS, Bangsberg DR, Lima VD, Alexander C, Bonner S, Yip B, Wood E, Dong WW, Montaner JS, Harrigan PR. Hogg RS, et al. Among authors: lima vd. PLoS Med. 2006 Sep;3(9):e356. doi: 10.1371/journal.pmed.0030356. PLoS Med. 2006. PMID: 16984218 Free PMC article.

4

Presenting plasma HIV RNA level and rate of CD4 T-cell decline.

Lima VD, Hogg RS, Montaner JS. Lima VD, et al. JAMA. 2007 Feb 28;297(8):805-6; author reply 806-7. doi: 10.1001/jama.297.8.805-b. JAMA. 2007. PMID: 17327517 No abstract available.

5

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, Montaner JS. Lima VD, et al. AIDS. 2007 Mar 30;21(6):685-92. doi: 10.1097/QAD.0b013e32802ef30c. AIDS. 2007. PMID: 17413689

6

The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

Lima VD, Geller J, Bangsberg DR, Patterson TL, Daniel M, Kerr T, Montaner J, Hogg RS. Lima VD, et al. AIDS. 2007 May 31;21(9):1175-83. doi: 10.1097/QAD.0b013e32811ebf57. AIDS. 2007. PMID: 17502728

7

Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.

Phillips E, Gutiérrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS. Phillips E, et al. Among authors: lima vd. AIDS. 2007 Jul 31;21(12):1561-8. doi: 10.1097/QAD.0b013e3282170a9d. AIDS. 2007. PMID: 17630551

8

Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting.

Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, Wood E, Montaner JS, Hogg RS. Joy R, et al. Among authors: lima vd. J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):500-5. doi: 10.1097/QAI.0b013e3181648dfd. J Acquir Immune Defic Syndr. 2008. PMID: 18197117

9

Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.

Phillips E, Hayden A, Gutiérrez S, Jahnke N, Yip B, Lima VD, Hogg RS, Harrigan PR, Montaner JS. Phillips E, et al. Among authors: lima vd. AIDS. 2008 Feb 19;22(4):548-9. doi: 10.1097/QAD.0b013e3282f4a0ed. AIDS. 2008. PMID: 18301076 No abstract available.

10

Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.

Lima VD, Gill VS, Yip B, Hogg RS, Montaner JS, Harrigan PR. Lima VD, et al. J Infect Dis. 2008 Jul 1;198(1):51-8. doi: 10.1086/588675. J Infect Dis. 2008. PMID: 18498238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters